SMTL ID : 8uud.1

BCX2627 complexed with human FVIIa and soluble Tissue Factor.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

hetero-1-1-1-1-mer

Ligands

1 x BGC: beta-D-glucopyranose(Post Translational Modification)

BGC.1: 3 residues within 4Å: Chain A: Q.49, S.52, P.54 No protein-ligand interaction detected (PLIP)

1 x FUC: alpha-L-fucopyranose(Post Translational Modification)

FUC.2: 7 residues within 4Å: Chain A: G.58, S.60, F.71, C.72, L.73 Chain D: R.41, F.50 4 PLIP interactions: 3 interactions with chain D, 1 interactions with chain A Hydrophobic interactions: D:F.50 Hydrogen bonds: D:R.41, D:R.41, A:S.60

9 x CA: CALCIUM ION(Non-covalent)

CA.3: 5 residues within 4Å: Chain A: D.46, G.47, Q.49, D.63, Q.64 5 PLIP interactions: 5 interactions with chain A Metal complexes: A:D.46, A:G.47, A:D.63, A:D.63, A:Q.64 CA.4: 4 residues within 4Å: Chain A: E.7, E.26, E.29 Ligands: CA.5 No protein-ligand interaction detected (PLIP) CA.5: 6 residues within 4Å: Chain A: E.7, E.16, E.26, E.29 Ligands: CA.4, CA.6 No protein-ligand interaction detected (PLIP) CA.6: 8 residues within 4Å: Chain A: A.1, N.2, E.6, E.7, E.16, E.26 Ligands: CA.5, CA.7 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:A.1 CA.7: 5 residues within 4Å: Chain A: A.1, E.6, E.16, E.20 Ligands: CA.6 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:A.1 CA.8: 3 residues within 4Å: Chain A: E.14, R.15, E.19 No protein-ligand interaction detected (PLIP) CA.9: 1 residues within 4Å: Chain A: E.20 No protein-ligand interaction detected (PLIP) CA.10: 2 residues within 4Å: Chain A: E.25, E.29 No protein-ligand interaction detected (PLIP) CA.11: 4 residues within 4Å: Chain B: E.58, D.60, E.63, E.68 4 PLIP interactions: 4 interactions with chain B Metal complexes: B:E.58, B:D.60, B:E.63, B:E.68

1 x XGX: (1P)-2'-[(4-carbamimidoylphenyl)carbamoyl]-4'-ethenyl-4-[(2-methylpropyl)carbamoyl][1,1'-biphenyl]-2-carboxylic acid(Non-covalent)

XGX.12: 20 residues within 4Å: Chain B: Q.24, L.25, H.41, T.86, T.87, D.90, D.186, S.187, C.188, K.189, G.190, S.192, V.210, S.211, W.212, G.213, G.215, C.216, T.218, G.223 11 PLIP interactions: 11 interactions with chain B Hydrophobic interactions: B:H.41, B:T.87, B:K.189, B:V.210 Hydrogen bonds: B:D.186, B:G.190, B:S.192, B:S.211, B:G.215 Salt bridges: B:H.41 pi-Stacking: B:H.41

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Krishnan, R., Structure based Drug design of human Factor VIIa Inhibitors. To be Published

Release Date

2024-11-27

Peptides

Factor VII light chain: A
Coagulation factor VII Heavy Chain: B
Tissue factor: C
Tissue factor: D

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
L

B
H

C
T

D
U

Factor VII light chain

Coagulation factor VII Heavy Chain

Tissue factor

Tissue factor

Related Entries With Identical Sequence